3 studies found for:    15585754 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies
Condition: Advanced Malignancy
Intervention:
2 Completed A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Trastuzumab, Docetaxel;   Drug: Trastuzumab, Docetaxel, Bevacizumab;   Drug: Trastuzumab+Docetaxel+NPLD;   Drug: Trastuzumab+Docetaxel+NPLD+Bevacizumab
3 Terminated Temodar and Sutent as Therapy for Melanoma
Condition: Metastatic Malignant Melanoma
Intervention: Drug: Temozolomide and SU11248

Indicates status has not been verified in more than two years